ASGR2 and chronic thromboembolic pulmonary hypertension: Multivariate stepwise regression analysis revealed that pre-BPA ASGR2 levels were associated with HDL-C and PLT count (both <i>P</i> < 0.001), while post-BPA ASGR2 levels were associated with LYM% (<i>P</i> < 0.05).<h4>Conclusion</h4>Serum levels of ASGR2 may be a biomarker for the effectiveness of BPA treatment in CTEPH patients.